Search

everythinglearnresearchcommunity

for

Search:↓

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Activating Tgr5 may help treat hair loss and bone loss.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

EGFR inhibitors can cause unusual localized hair growth.

The new nanoparticles could improve melanoma treatment by working better than current options.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Entospletinib effectively prevents eye and skin GVHD in mice.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Reporter characteristics affect detection of hair loss from cancer therapy.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

TPA is about 50 times more effective at promoting tumors than MZ.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.